MarketInOut Stock Screener Log In | Sign Up

SeaStar Medical Holding Corp Wt

NASDAQ • Healthcare • Biotechnology • Quote as of 10/28/2026 15:49
SeaStar Medical Holding Corp Wt stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization10.74 mln
Float4.37 mln
Earnings Date11/13/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.19
Caution advised

Relative Strength

90 / 100
Top performer

Debt / Equity

0.03
Debt-free

Pre-Tax Margin

-795%
Severely loss-making

ROE

-185
Deeply negative

Business Description

SeaStar Medical, founded in 2007 and based in Denver, Colorado, makes medical devices designed to protect vital organs from severe immune overreactions. Its core technology works by calming overactive immune cells that would otherwise cause life-threatening inflammation, and is currently used to treat children with serious kidney damage caused by sepsis. The company is also running clinical trials for an adult version of this treatment and is exploring its use in several other conditions affecting the heart and kidneys.

Key Fundamentals

EPS-3.91
ROE-185
RPS0.48
ROIC-1,102
ROA-118
Interest Cover-518
EBITDA, mln-10.10
EV / EBITDA-0.01
Revenue, mln1.71

Quote Details

Last 0.0167
Change 0.0014 (9.15%)
Open 0.0152
Volume 198,098
Turnover 3,308.24
Average Volume 28,685

Financial Ratios

Pre-Tax Profit Margin-795
Leverage Ratio2.01
Current Ratio1.89
Price / Book0.01
Debt / Equity0.03
Price / Sales5.28

Financial Strength

Altman Z-Score-28.68
Piotroski F-Score 4 / 9
Beneish M-Score-2.19

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -17.33% 4 / 100   
1 Month 5.63% 86 / 100   
2 Months 4.37% 77 / 100   
6 Months -43.96% 14 / 100   
1 Year -62.72% 14 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog